FDA approves first immunotherapy regimen for breast cancer

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. (CNN Photo)

The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

Posted: Mar 9, 2019 10:17 AM

(CNN) -- The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.

The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and chemotherapy: Tecentriq and Abraxane, respectively.

The FDA's decision comes after an October study published in the New England Journal of Medicine found that the therapy extended progression-free survival -- the amount of time in which a patient's cancer does not worsen. In the PD-L1 subgroup, the median progression-free survival for those receiving the combination treatment was 7.4 months, versus 4.8 months for those getting the chemotherapy with placebo, according to the FDA's announcement. The trial was funded by Genentech Inc., the maker of Tecentriq.

"This is the first time immunotherapy has worked in such a difficult to treat cancer, and is a huge step forward for these breast cancer patients," lead study author Dr. Peter Schmid of Queen Mary University of London said in an October statement.

Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, said the FDA's decision to grant the treatment accelerated approval was "the right thing to do" but cautioned that it's not the end of the story.

"The FDA has approved it based on progression-free survival with the hope that later on ... data will show that the treatment actually makes women live longer," said Brawley, who was not involved in researching the treatment.

This FDA says it grants accelerated approvals to "drugs that treat serious conditions, and that fill an unmet medical need" based on data that suggests, but may not directly measure, a clinical benefit. Drugmakers are still required to confirm that the drug is beneficial through later trials. If that happens, the drug may receive a traditional FDA approval. Otherwise, the agency may decide to pull the drug, as has happened in the past.

In this case, the drugmaker is expected to submit a final report detailing subsequent findings in September 2020, according to the approval letter from the FDA to Genentech.

Tecentriq, the brand name of the immunotherapy drug atezolizumab, was previously approved to treat other specific types of urinary and lung cancers.

Breast cancer patients on the newly approved therapy most commonly reported adverse reactions like hair loss, fatigue, nausea, headaches and decreased appetites, according to the FDA.

Dr. Larry Norton, director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center, told CNN in October that scientists are learning "so much and so rapidly about other ways to stimulate the immune system" that he predicts an "explosion of well-designed studies that will push the agenda forward."

Norton, who was not involved in the October study, said "this is just the beginning of using immunotherapy for breast cancer."

Triple-negative breast cancer
About 15% of breast cancers are triple-negative, according to the National Breast Cancer Foundation. The protein PD-L1 may be found in roughly a fifth of those cancers, research has shown.

Triple-negative breast cancer is most likely to affect Hispanic and African-American women and those with a BRCA1 gene mutation. It also tends to appear among women in their 40s and 50s.

"It is particularly tragic that those affected are often young," Queen Mary University's Schmid said. "We have desperately been looking for better treatment options."

When breast cancer cells test negative for estrogen, progesterone or human epidermal growth factor 2 (HER2), it's called a triple-negative breast cancer. Therefore, it does not respond to any of the available hormonal cancer treatments.

It does respond to chemotherapy. However, cancer cells can quickly develop resistance to chemo drugs, allowing them to spread to other parts of the body, reducing survival rates.

How does it work?
Cancers have a way of eluding the body's immune system, which recognizes them as part of the body. That's where Tecentriq comes in: It's an antibody that attaches to the cancer cell and inactivates the PD-L1 protein, which is responsible for telling the immune system, "don't attack me."

Chemotherapy is also needed to "rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader.

"We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said, "enabling people's own immune system to get at it."

Norton said in October that "I think the expectation is, this will change the standard of care.

"This is a real advance that is going to allow us to help more people."

Terre Haute
Partly Cloudy
23° wxIcon
Hi: 37° Lo: 22°
Feels Like: 16°
Robinson
Partly Cloudy
19° wxIcon
Hi: 38° Lo: 20°
Feels Like: 11°
Indianapolis/Eagle Creek
Cloudy
24° wxIcon
Hi: 31° Lo: 21°
Feels Like: 13°
Paris
Partly Cloudy
19° wxIcon
Hi: 35° Lo: 21°
Feels Like: 11°
Mattoon/Charleston
Partly Cloudy
16° wxIcon
Hi: 38° Lo: 20°
Feels Like: 7°
Terre Haute
Partly Cloudy
23° wxIcon
Hi: 35° Lo: 21°
Feels Like: 16°
Terre Haute
Partly Cloudy
23° wxIcon
Hi: 37° Lo: 21°
Feels Like: 16°
Cloudy, Breezy & Cold
WTHI Planner
WTHI Temps
WTHI Radar

Latest Video

Image

Wednesday: Becoming sunny. Breezy. High: 38°

Image

THN Shakamak

Image

West Vigo Bloomfield

Image

Loogootee Evan Memorial

Image

North Daviess Dugger Union

Image

Vincennes Rivet Evan Central

Image

Vin Lincoln Evan Mater Dei

Image

TH North Nothview

Image

Caitlyn Newton

Image

Climate change education

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1076532

Reported Deaths: 20153
CountyCasesDeaths
Cook4358889065
DuPage692851153
Will58408870
Lake53439886
Kane46063677
Winnebago26295407
Madison24398463
St. Clair22343426
McHenry21712248
Champaign15485102
Peoria15054241
Sangamon14548235
McLean13244159
Tazewell11944245
Rock Island11919303
Kankakee11488179
Kendall971578
LaSalle9478247
Macon8836179
Vermilion7538113
DeKalb749192
Adams7371117
Williamson6196116
Boone554977
Whiteside5261173
Clinton503285
Coles470380
Ogle460371
Knox4589142
Grundy438754
Effingham431169
Jackson418767
Henry401476
Marion3994112
Macoupin384994
Franklin384769
Randolph371568
Livingston364766
Monroe358770
Stephenson353274
Jefferson3435104
Morgan325989
Woodford320266
Logan309456
Montgomery305342
Lee304872
Bureau300484
Christian298673
Fayette291153
Perry267060
Iroquois259756
Fulton256949
Jersey222556
Lawrence217630
McDonough215051
Saline203053
Douglas199533
Union199332
Shelby197035
Crawford176134
Cass175131
Bond173824
Warren158644
Pike154346
Richland153644
Wayne152043
Hancock148634
Jo Daviess148524
Clark147730
Washington145225
Edgar144353
Carroll142633
Ford139049
Moultrie137428
White133430
Clay131240
Greene125742
Johnson121115
Wabash117914
Piatt117416
Mercer117229
Mason116640
De Witt114727
Cumberland108527
Jasper104015
Massac101831
Menard88010
Hamilton71717
Marshall67013
Schuyler62416
Pulaski6133
Brown61011
Stark49320
Edwards4629
Henderson45316
Calhoun4404
Alexander3897
Gallatin3884
Scott3851
Putnam3462
Hardin3038
Pope2472
Unassigned1050
Out of IL320

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 595436

Reported Deaths: 9466
CountyCasesDeaths
Marion822851311
Lake44626670
Allen32165543
Hamilton28684308
St. Joseph26917378
Elkhart24173343
Vanderburgh18856236
Tippecanoe17638125
Johnson14687289
Porter14513163
Hendricks14010242
Madison10715216
Vigo10540177
Clark10349135
Monroe9189108
Delaware8956134
LaPorte8867158
Howard7982140
Kosciusko791380
Warrick652994
Hancock646999
Bartholomew631096
Floyd6205107
Wayne5984159
Grant5874110
Dubois547175
Boone538867
Morgan524192
Henry497764
Marshall495384
Cass475362
Dearborn464545
Noble463157
Jackson417846
Shelby405680
Lawrence383876
Clinton367840
Gibson360058
DeKalb339163
Montgomery338152
Harrison333643
Knox329839
Miami312743
Steuben309343
Adams297435
Whitley297225
Wabash294947
Ripley294345
Putnam288047
Jasper285234
Huntington284959
White269138
Daviess263073
Jefferson253838
Decatur243482
Fayette242948
Greene237062
Posey234427
Wells231347
LaGrange225061
Clay219032
Scott218538
Randolph209845
Jennings193935
Sullivan189632
Spencer184319
Fountain180527
Washington179321
Starke172743
Jay163922
Fulton161130
Owen161137
Carroll153915
Orange152933
Rush151618
Perry149327
Vermillion145833
Franklin144433
Tipton129232
Parke12918
Pike114326
Blackford109222
Pulaski95337
Newton89821
Brown85931
Benton85310
Crawford7719
Martin70713
Warren6637
Switzerland6235
Union6146
Ohio4727
Unassigned0374